Becton, Dickinson and Company (BDX)
(Delayed Data from NYSE)
$231.55 USD
+1.07 (0.46%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $231.63 +0.08 (0.03%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth F Momentum C VGM
Price, Consensus and EPS Surprise
BDX 231.55 +1.07(0.46%)
Will BDX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for BDX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BDX
Philips (PHG) Receives FDA Warning Letter Regarding CT Systems
DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
BDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Revvity's (RVTY) New Launch to Boost Tuberculosis Testing
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
Veeva's (VEEV) AI Partner Program to Develop GenAI Solutions
Other News for BDX
How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?
BCAL Diagnostics Advances Breast Cancer Detection Test
Madison Sustainable Equity Fund Q1 2024 Investment Strategy Letter
Stocks with the least price swings, most attractive option-sale candidates - JPM
Madison Investors Fund Q1 2024 Investment Strategy Letter